Authors:
CHALLITAEID PM
PENICHET ML
SHIN SU
POLES T
MOSAMMAPARAST N
MAHMOOD K
SLAMON DJ
MORRISON SL
ROSENBLATT JD
Citation: Pm. Challitaeid et al., A B7.1-ANTIBODY FUSION PROTEIN RETAINS ANTIBODY SPECIFICITY AND ABILITY TO ACTIVATE VIA THE T-CELL COSTIMULATORY PATHWAY, The Journal of immunology, 160(7), 1998, pp. 3419-3426
Citation: Hs. Shin et al., CHARACTERIZATION OF PHOSGEN-FREE MIC WASTE-WATER, Journal of environmental science and health. Part A: Environmental science and engineering, 32(8), 1997, pp. 2139-2153
Authors:
SHIN SU
WU DF
RAMANATHAN R
PARDRIDGE WM
MORRISON SL
Citation: Su. Shin et al., FUNCTIONAL AND PHARMACOKINETIC PROPERTIES OF ANTIBODY-AVIDIN FUSION PROTEINS, The Journal of immunology, 158(10), 1997, pp. 4797-4804
Authors:
SHIN SU
FRIDEN P
PARDRIDGE WM
MORRISON SL
Citation: Su. Shin et al., GENETIC-ENGINEERING OF ANTIBODY FUSION PROTEINS TO CROSS THE BLOOD-BRAIN-BARRIER, The FASEB journal, 9(4), 1995, pp. 946-946
Citation: Sl. Morrison et Su. Shin, GENETICALLY-ENGINEERED ANTIBODIES AND THEIR APPLICATION TO BRAIN DELIVERY, Advanced drug delivery reviews, 15(1-3), 1995, pp. 147-175
Authors:
SHIN SU
FRIDEN P
MORAN M
OLSON T
KANG YS
PARDRIDGE WM
MORRISON SL
Citation: Su. Shin et al., TRANSFERRIN ANTIBODY FUSION PROTEINS ARE EFFECTIVE IN BRAIN TARGETING, Proceedings of the National Academy of Sciences of the United Statesof America, 92(7), 1995, pp. 2820-2824
Citation: Su. Shin et al., FUNCTIONAL-PROPERTIES OF ANTIBODY INSULIN-LIKE GROWTH-FACTOR FUSION PROTEINS, The Journal of biological chemistry, 269(7), 1994, pp. 4979-4985